MI: myocardial infarction
Patients often feel disappointed not because the medication fails, but because their expectations were too high
In a Phase Ib study for patients with Type 2 Diabetes (T2D), although no significant improvement in HbA1c levels was observed, pemvidutide still achieved a weight reduction of 8.5% at the end of a 12-week course compared to placebo
Liraglutide has been shown to exhibit antioxidant and anti-inflammatory properties that reduce eNOS uncoupling and increase NO bioavailability, NO bioavailability is thereby maintained, endothelium-mediated vasorelaxation is preserved, and vascular remodeling and fibrosis are prevented
It also makes a peptide called epithalamin
Injury healing: Higher doses (20 to 30 units daily) during shorter, intensive cycles (6 to 8 weeks) maximize the tissue repair effects of BPC-157 and TB-500 while KPV controls inflammation that could impede healing